Imuran Dosing in Crohn's Disease Study
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Crohn's Disease
Related studies linked through entity extraction aliases.
Trial of Growth Hormone Therapy in Pediatric Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE3
STA-5326 in Crohn's Disease Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Quality of Life in Pediatric Inflammatory Bowel Disease
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Remission in Subjects With Crohn's Disease, 1 Year Phase
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
CP-461 for the Treatment of Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2